Remepy
Gal Gorelik is a seasoned project manager currently working at Remepy since December 2024. Previously, Gal served as a Clinical Project Manager at Reichman University from June 2024 to November 2024 and as an Analyst at SpotitEarly from April 2023 to June 2024. Prior roles include Production Center Specialist at Trigo during 2022-2023 and Risk Analyst at EverC from 2020 to 2022. Gal is pursuing a Bachelor of Science in Psychology & Biology at Tel Aviv University, with an expected graduation in October 2024.
This person is not in any teams
Remepy
Remepy is Pioneering Hybrid Drugs™. We believe that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs™. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™. Remepy’s Digital Molecules™ are designed to be the software components within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug. The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.